The best health stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
The top health stocks included on this page all trade on the S&P 500, have an analyst recommendation of "Buy" or better and are sorted by year-to-date performance.
Stock picking services use algorithms, data analytics and expert insights to identify promising stocks, aiding investors in strategic decision-making.
If you don't have the time or expertise to research stocks on your own, consider stock picking services and research tools to help you choose.
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer.
Eli Lilly and Company stock opened the day at $913.49 after a previous close of $906.70. The latest price was $910.55 (25-minute delay). Eli Lilly and Company is listed on the NYSE, has a trailing 12-month revenue of around USD65.2 billion and employs 50,000 staff.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas.
Novo Nordisk A/S stock opened the day at $36.83 after a previous close of $36.53. The latest price was $36.82 (25-minute delay). Novo Nordisk A/S is listed on the NYSE, has a trailing 12-month revenue of around USD$309.1 billion and employs 68,794 staff.
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.
UnitedHealth Group Incorporated stock opened the day at $279.14 after a previous close of $275.59. The latest price was $269.54 (25-minute delay). UnitedHealth Group Incorporated is listed on the NYSE, has a trailing 12-month revenue of around USD$447.6 billion and employs 390,000 staff.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Johnson-and-Johnson stock opened the day at $237.40 after a previous close of $235.37. The latest price was $235.42 (25-minute delay). Johnson-and-Johnson is listed on the NYSE, has a trailing 12-month revenue of around USD$94.2 billion and employs 138,200 staff.
Merck & Co. , Inc. operates as a healthcare company worldwide.
Merck-and-Company stock opened the day at $116.17 after a previous close of $114.18. The latest price was $115.68 (25-minute delay). Merck-and-Company is listed on the NYSE, has a trailing 12-month revenue of around USD$65 billion and employs 73,000 staff.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.